SI2023901T1 - Farmacevtski pripravek, ki vsebuje tetrahidrolipstatin - Google Patents

Farmacevtski pripravek, ki vsebuje tetrahidrolipstatin

Info

Publication number
SI2023901T1
SI2023901T1 SI200730351T SI200730351T SI2023901T1 SI 2023901 T1 SI2023901 T1 SI 2023901T1 SI 200730351 T SI200730351 T SI 200730351T SI 200730351 T SI200730351 T SI 200730351T SI 2023901 T1 SI2023901 T1 SI 2023901T1
Authority
SI
Slovenia
Prior art keywords
tetrahydrolipstatin
pharmaceutical composition
carrageenan
pharmaceutically acceptable
solid dosage
Prior art date
Application number
SI200730351T
Other languages
English (en)
Inventor
Ljubin Tijana Stanic
Peterka Tanja Rozman
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI2023901T1 publication Critical patent/SI2023901T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200730351T 2006-06-27 2007-06-25 Farmacevtski pripravek, ki vsebuje tetrahidrolipstatin SI2023901T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06013188A EP1872777A1 (en) 2006-06-27 2006-06-27 Pharmaceutical composition comprising tetrahydrolipstatin
PCT/EP2007/005598 WO2008000420A1 (en) 2006-06-27 2007-06-25 Pharmaceutical composition comprising tetrahydrolipstatin
EP07726152A EP2023901B1 (en) 2006-06-27 2007-06-25 Pharmaceutical composition comprising tetrahydrolipstatin

Publications (1)

Publication Number Publication Date
SI2023901T1 true SI2023901T1 (sl) 2011-02-28

Family

ID=37142317

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730351T SI2023901T1 (sl) 2006-06-27 2007-06-25 Farmacevtski pripravek, ki vsebuje tetrahidrolipstatin

Country Status (7)

Country Link
EP (2) EP1872777A1 (sl)
AT (1) ATE471712T1 (sl)
BR (1) BRPI0713062A2 (sl)
CA (1) CA2656069A1 (sl)
DE (1) DE602007007320D1 (sl)
SI (1) SI2023901T1 (sl)
WO (1) WO2008000420A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101833250B1 (ko) 2010-10-25 2018-03-02 한미사이언스 주식회사 저융점 활성 성분을 포함하는 구형 압출과립, 이를 포함하는 경구 투여용 정제 및 이의 제조 방법
UA122403C2 (uk) * 2014-12-17 2020-11-10 Емпрос Фарма Аб Композиція орлістату та акарбози з модифікованим вивільненням для лікування ожиріння і пов'язаних метаболічних порушень

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
PT1296656E (pt) * 2000-06-27 2006-12-29 Hoffmann La Roche Processo para a preparação de uma composição
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition

Also Published As

Publication number Publication date
EP1872777A1 (en) 2008-01-02
DE602007007320D1 (de) 2010-08-05
CA2656069A1 (en) 2008-01-03
WO2008000420A1 (en) 2008-01-03
EP2023901B1 (en) 2010-06-23
ATE471712T1 (de) 2010-07-15
BRPI0713062A2 (pt) 2012-04-10
EP2023901A1 (en) 2009-02-18

Similar Documents

Publication Publication Date Title
WO2007016563A3 (en) Alcohol resistant pharmaceutical formulations
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
ECSP088239A (es) Composición de liberación de fármaco sostenida
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
TW200744677A (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
IL188744A0 (en) High drug load formulations and dosage forms
MX2009007784A (es) Composiciones de tiacumicinas estables.
WO2010066749A3 (en) Ulipristal acetate tablets
EA201170512A1 (ru) Композиция для перорального введения
MY152951A (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
WO2008003050A3 (en) Gallium nitrate formulations
WO2009068708A3 (es) Composición farmacéutica de liberación sostenida de somatostatina o un análogo suyo
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
WO2012085249A3 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
WO2008092219A3 (en) Pharmaceutical composition comprising tramadol and ketoprofen
SI2023901T1 (sl) Farmacevtski pripravek, ki vsebuje tetrahidrolipstatin
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
SE0000303D0 (sv) Novel compounds
WO2007114946A3 (en) Acid-sensitive linkers for drug delivery
WO2011161223A3 (en) Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
WO2007116297A3 (en) Use of aminapthone for the preparation of a medicament for treating arteriophaties